Presentation is loading. Please wait.

Presentation is loading. Please wait.

Risk of Pleural Recurrence After Computed Tomographic-Guided Percutaneous Needle Biopsy in Stage I Lung Cancer Patients  Masayoshi Inoue, MD, PhD, Osamu.

Published byRatna Kurniawan Modified over 5 years ago

Similar presentations

Presentation on theme: "Risk of Pleural Recurrence After Computed Tomographic-Guided Percutaneous Needle Biopsy in Stage I Lung Cancer Patients  Masayoshi Inoue, MD, PhD, Osamu."— Presentation transcript:

1 Risk of Pleural Recurrence After Computed Tomographic-Guided Percutaneous Needle Biopsy in Stage I Lung Cancer Patients  Masayoshi Inoue, MD, PhD, Osamu Honda, MD, PhD, Noriyuki Tomiyama, MD, PhD, Masato Minami, MD, PhD, Noriyoshi Sawabata, MD, PhD, Yoshihisa Kadota, MD, PhD, Yasushi Shintani, MD, PhD, Yuko Ohno, PhD, Meinoshin Okumura, MD, PhD  The Annals of Thoracic Surgery  Volume 91, Issue 4, Pages (April 2011) DOI: /j.athoracsur Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Disease-free survival (DFS) rates in p stage I lung cancer patients according to diagnostic method. No significant difference was found between the computed tomographic-guided percutaneous core needle biopsy (CTGNB) and transbronchial biopsy (TBB) or open lung biopsy (OLB) groups. (NS = not significant.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Disease-free survival rates (DFS) according to tumor location. (A) Patients with a subpleural (SPL) lesion had a significantly worse outcome than those with a nonSPL lesion. (B) DFS rates in patients with a subpleural lesion according to diagnostic method. There was no difference in regard to the diagnosis between the computed tomographic-guided percutaneous core needle biopsy (CTGNB) and transbronchial biopsy (TBB), or open lung biopsy (OLB) groups. (NS = not significant.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Risk of Pleural Recurrence After Computed Tomographic-Guided Percutaneous Needle Biopsy in Stage I Lung Cancer Patients  Masayoshi Inoue, MD, PhD, Osamu."

Similar presentations

Blunt Tracheal Transection Repair Requiring Open Abdominal Management

Blunt Tracheal Transection Repair Requiring Open Abdominal Management
Trimodality Therapy for an Advanced Thymic Carcinoma With Both Aorta and Vena Cava Invasion  Tohru Momozane, MD, Masayoshi Inoue, MD, PhD, Yasushi Shintani,

Trimodality Therapy for an Advanced Thymic Carcinoma With Both Aorta and Vena Cava Invasion  Tohru Momozane, MD, Masayoshi Inoue, MD, PhD, Yasushi Shintani,
Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread  Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,

Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread  Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
B-Type Natriuretic Peptide as a Predictor of Postoperative Cardiopulmonary Complications in Elderly Patients Undergoing Pulmonary Resection for Lung Cancer 

B-Type Natriuretic Peptide as a Predictor of Postoperative Cardiopulmonary Complications in Elderly Patients Undergoing Pulmonary Resection for Lung Cancer 
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Andranik Petrosyan, MD, Patrice Bergeron, MD 

Andranik Petrosyan, MD, Patrice Bergeron, MD 
Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity to Chemoradiotherapy in Non-Small Cell Lung Cancer  Yasushi Shintani, MD, PhD, Akira.

Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity to Chemoradiotherapy in Non-Small Cell Lung Cancer  Yasushi Shintani, MD, PhD, Akira.
Sarcoid-Like Reaction Mimics Progression of Disease After Induction Chemotherapy for Lung Cancer  Masayuki Chida, MD, PhD, Takashi Inoue, MD, Koichi Honma,

Sarcoid-Like Reaction Mimics Progression of Disease After Induction Chemotherapy for Lung Cancer  Masayuki Chida, MD, PhD, Takashi Inoue, MD, Koichi Honma,
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Nodal Staging of Stereotactic Ablative Body Radiotherapy Patients  Macarena R.

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Nodal Staging of Stereotactic Ablative Body Radiotherapy Patients  Macarena R.
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,
Operative Results and Outcomes in Children With Shone's Anomaly

Operative Results and Outcomes in Children With Shone's Anomaly
Clinical Value of Serum Cytokeratin 19 Fragment and Sialyl-Lewis X in Non-Small Cell Lung Cancer  Shinjiro Mizuguchi, MD, PhD, Noritoshi Nishiyama, MD,

Clinical Value of Serum Cytokeratin 19 Fragment and Sialyl-Lewis X in Non-Small Cell Lung Cancer  Shinjiro Mizuguchi, MD, PhD, Noritoshi Nishiyama, MD,
Survival After Resection for Metastatic Testicular Nonseminomatous Germ Cell Cancer to the Lung or Mediastinum  Kenneth A. Kesler, MD, Laura E. Kruter,

Survival After Resection for Metastatic Testicular Nonseminomatous Germ Cell Cancer to the Lung or Mediastinum  Kenneth A. Kesler, MD, Laura E. Kruter,
Endoscopic Ultrasound-Guided Fine Needle Aspiration for Diagnosis of Recurrent Nonsmall Cell Lung Cancer  Rebecca Lai, MD  The Annals of Thoracic Surgery 

Endoscopic Ultrasound-Guided Fine Needle Aspiration for Diagnosis of Recurrent Nonsmall Cell Lung Cancer  Rebecca Lai, MD  The Annals of Thoracic Surgery 

Similar presentations

Ads by Google